Wearable TENS Device Cleared for Fibromyalgia Treatment

The Quell neuromodulation device has received the FDA De Novo authorization for use as an aid in reducing the symptoms of fibromyalgia.

Related Keywords

Shain Gozani , ,Drug Administration De Novo ,Patient Global Impression ,Fibromyalgia Impact Questionnaire ,Chief Executive Officer ,